A plain-language guide

familial hypercholesterolemia

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Early map · 7 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. familial hypercholesterolemia is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's familial hypercholesterolemia?

Familial hypercholesterolemia is an inherited disorder marked by lifelong very high LDL cholesterol and an increased risk of early heart attack.

Features mapped5
Treatments mapped1
Published sources4
Last reviewed2026-08-04

Signs and symptoms

Corneal arcus

A pale ring around the edge of the cornea (corneal arcus) can develop in familial hypercholesterolemia from cholesterol deposits.

Limited evidenceSource: PMID:41271369
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:143890
Notesplain_language confirmed from PMID:41271369 via curation 2026-07-03 [llm:fable-5]. | regrounded primary OMIM:143890 -> PMID:41271369 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Elevated circulating LDL-C concentration

Very high levels of LDL cholesterol (the 'bad' cholesterol) are a defining feature of familial hypercholesterolemia.

Limited evidenceSource: PMID:34456200
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:35882565, OMIM:143890
Notesplain_language confirmed from PMID:35882565 via curation 2026-07-03 [llm:fable-5]. | regrounded primary OMIM:143890 -> PMID:34456200 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Coronary artery atherosclerosis

Familial hypercholesterolemia leads to early coronary artery disease, a buildup of cholesterol in the arteries supplying the heart.

Limited evidenceCurated reference: OMIM:143890
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:35882565
Notesplain_language confirmed from PMID:35882565 via curation 2026-07-03 [llm:fable-5].
Last reviewed2026-07-03

Autosomal dominant inheritance

Familial hypercholesterolemia is usually inherited in an autosomal dominant pattern, so a single altered gene copy is enough to produce it.

Limited evidenceCurated reference: OMIM:143890
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42291074
Notesplain_language confirmed from PMID:42291074 via curation 2026-07-03 [llm:fable-5].
Last reviewed2026-07-03

Tendon xanthomatosis

Tendon xanthomas, firm cholesterol deposits in the tendons, can occur in familial hypercholesterolemia.

Limited evidenceSource: PMID:34456200
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:35882565, OMIM:143890
Notesplain_language confirmed from PMID:35882565 via curation 2026-07-03 [llm:fable-5]. | regrounded primary OMIM:143890 -> PMID:34456200 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

statin

In familial hypercholesterolemia, high-intensity statins (often with ezetimibe) are used to lower LDL cholesterol.

Used to help with: Elevated circulating LDL-C concentration.

Limited evidenceSource: PMID:42250972
The source text this rests on
“…we evaluated 30 FH subjects on high-intensity statins plus ezetimibe and with an off-target LDL-C.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42250972 via curation 2026-07-03
Last reviewed2026-07-03

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 4 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

OMIM:143890 · Orphanet/HPO annotations for Hypercholesterolemia, familial, 1
PMID:34456200 · Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 2020.
PMID:41271369 · Corneal arcus and Achilles tendon thickness reflect circulating lipoprotein(a) levels in familial hypercholesterolemia: Implication for predicting future cardiovascular events.
PMID:42250972 · Effect of add-on PCSK9 inhibitors on endocan and arterial stiffness in heterozygous familial hypercholesterolemia: a two

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.

Get the Condition Packet Get the Medical Necessity Evidence Dossier